0001096906-24-000525.txt : 20240319
0001096906-24-000525.hdr.sgml : 20240319
20240319195906
ACCESSION NUMBER: 0001096906-24-000525
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUEMOELLER JOHN WALTER II
CENTRAL INDEX KEY: 0001568485
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54296
FILM NUMBER: 24765855
MAIL ADDRESS:
STREET 1: 305 SAN ANSELMO AVENUE
STREET 2: SUITE 300
CITY: SAN ANSELMO
STATE: CA
ZIP: 94960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC.
CENTRAL INDEX KEY: 0001514946
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 274092986
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (212) 751-0001
MAIL ADDRESS:
STREET 1: 6191 CORNERSTONE COURT, E
STREET 2: SUITE 114
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: AXIM INTERNATIONAL INC.
DATE OF NAME CHANGE: 20110309
4/A
1
form4.xml
PRIMARY DOCUMENT
X0508
4/A
2024-03-15
2024-03-19
0
0001514946
AXIM BIOTECHNOLOGIES, INC.
AXIM
0001568485
HUEMOELLER JOHN WALTER II
6191 CORNERSTONE COURT, E.
SUITE 114
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
0
Convertible Note
0.0100
2024-03-15
4
A
0
250000.0000
250000.0000
A
2026-01-23
2033-01-24
Common Stock
25000000.0000
30000000.0000
D
Convertible Note
0.0200
2024-03-15
4
A
0
250000.0000
250000.0000
A
2024-03-15
2034-03-01
Common Stock
12500000.0000
42500000.0000
D
Reporting Person acquired an Amended Convertible Promissory Note in the face amount of $250,000. The Note is convertible into shares of the Issuer's common stock at a price of $0.01 per share.
Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.
/s/ John W. Huemoeller II
2024-03-19